Ausgabe Sonderheft 2/1999
Inhalt (147 Artikel)
Mechanisms of Fluoroquinolone Resistance: An Update 1994–1998
Laura J. V. Piddock
Activity of Newer Fluoroquinolones In Vitro Against Gram-Positive Bacteria
George M. Eliopoulos
Fluoroquinolone Treatment of Skin and Skin Structure Infections
Adolf W. Karchmer
Use of Quinolones in Osteomyelitis and Infected Orthopaedic Prosthesis
Daniel P. Lew, Francis A. Waldvogel
Newer Quinolones in the Long Term Prophylaxis of Recurrent Urinary Tract Infections (UTI)
Silvester Krcméry, Juraj Hromec, Miroslava Tvrdikova, Mahmoud Hassan, Dusan Gulla
Outcome of Antibiotic Therapy with Ciprofloxacin in Chronic Bacterial Prostatitis
Wolfgang Weidner, Martin Ludwig, Elmar Brähler, Hans Gerd Schiefer
Antimicrobial Activity of Gatifloxacin Against Campylobacter jejuni and Anaerobic Bacteria
M. E. Erwin, R. N. Jones, M. S. Barrett, M. A. Pfaller, C. L. Hayward, G. V. Doern
Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams
Luc Dubreuil, E. Singer, M. F. Odou, F. Leblanc
Antianaerobic Activity of Gatifloxacin
Lois M. Ednie, Michael R. Jacobs, Peter C. Appelbaum
Grepafloxacin vs Pneumococci Resistant to Fluoroquinolones by a Putative Efflux Mechanism
Nigel P. Brenwald, Martin J. Gill, Richard Wise
Mutations to Quinolone Resistance in Pseudomonas aeruginosa and Enterococcus faecium
Shah Jalal, Nagwa El Amin, Naomasa Gotoh, Bengt Wretlind
Activity of Trovafloxacin Against Topoisomerases and GyrA/Gr1A Mutants of Staphylococcus aureus
Thomas D. Gootz, Richard P. Zaniewski, Suzanne L. Haskell, Frank S. Kaczmarek, Alison E. Maurice
Ofloxacin Selects First-Step ParC Mutations in Mycoplasma hominis Whereas Sparfloxacin Selects for First-Step GyrA Mutations
G. E. Kenny, P. A. Young, F. D. Cartwright, K. E. Sjostrom, W. M. Huang
Fluoroquinolone Resistance Mutations in the DNA Topoisomerase II Genes of Viridans Group Streptococci Clinical Isolates
Delia Balas, Irene González, Marios Georgiou, Fernando Alcaide, Josefina Liñares, Adela G. De La Campa
Nosocomial Superinfections with Gram-Negative Pathogens and Quinolone Resistance after Treatment with Ciprofloxacin vs Ofloxacin
Yehuda Carmeli, Matthew H. Samore
Resistant Mutants of Staphylococcus aureus with Ofloxacin in Comparison with Ciprofloxacin
Y. Rio, F. Jurin, J. Didion
Mechanisms and Frequency of Resistance to Moxifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus
Dilek Ince, Rahul Aras, David C. Hooper
Mechanisms and Frequency of Resistance to Gatifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus
Dilek Ince, Rahul Aras, David C. Hooper
Mutational Resistance to Quinolones in Staphylococci
Kenneth S. Thomson, Ellen S. Moland, Christine C. Sanders
Comparative In Vitro Activity of Grepafloxacin Against Selected Mutants and Clinical Isolates
C. J. Soussy, F. Leblanc
Synergistic Activity of Trovafloxacin with Other Agents
Melissa A. Visalli, Saralee Bajaksouzian, Michael R. Jacobs, Peter C. Appelbaum
Antimicrobial Activity of Moxifloxacin and Levofloxacin Photodegradation Products
C. M. Tobin, J. Sunderland, A. P. MacGowan, A. J. Hedges, L. O. White
Comparative Postantibiotic Effect of Sitafloxacin and Trovafloxacin on Methicillin-Resistant Staphylococcus aureus
E. J. Giamarellos-Bourboulis, P. Grecka, H. Sambatakou, Z. Chryssouli, H. Giamarellou
Comparative Antibiotic Activity Versus Vancomycin Intermediate-Susceptible Staphylococcus aureus
M. D. Huband, M. A. Cohen, J. W. Gage, S. R. VanderRoest
Activity of Trovafloxacin Against Micro-Organisms Isolated from Diabetic Patients with Lower Extremity Infections
K. Weiss, M. Laverdière, C. Restieri, L. Poirier
Moxifloxacin
A. Speciale, G. Aleo, K. La Ferla, R. Musumeci, F. Caccamo, G. Nicoletti
Antimicrobial Activity of Gatifloxacin Tested Against 1676 Gram-Positive Cocci Resistant to Ciprofloxacin
R. N. Jones, M. A. Pfaller, G. V. Doern, M. Beach
Antistreptococcal Activity of Gatifloxacin
Ronald N. Jones, David M. Johnson, Meridith E. Erwin, Mondell L. Beach, Douglas J. Biedenbach
Antibacterial Activity of Gatifloxacin in Obstetrics and Gynaecology
Koji Izumi, Hiroshige Mikamo, Kyoko Kawazoe, Teruhiko Tamaya
In Vitro Antibacterial Activities of Gatifloxacin (AM-1155) Against Clinical Pathogens Recently Isolated from Various Infections
Youko Tsurumaki, Hinako Manda, Masaya Takei, Yasuo Oomori
Ofloxacin Photodegradation Products Possess Antimicrobial Activity
J. Sunderland, C. M. Tobin, L. O. White, A. P. MacGowan, A. J. Hedges
Antimicrobial Spectrum of Gatifloxacin in the SENTRY Program
R. N. Jones, M. A. Pfaller, G. V. Doern, M. Beach
Gatifloxacin Susceptibility Testing Interpretive Criteria and Quality Control Guidelines for Dilution and Disk Diffusion Methods
K. C. Kugler, R. N. Jones, D. J. Biedenbach, M. E. Erwin, M. A. Pfaller, G. V. Doern
In Vitro Antimicrobial Activity of Gatifloxacin Against N. gonorrhoeae and H. influenzae
Douglas J. Biedenbach, R. N. Jones, M. L. Beach, M. S. Barrett, D. M. Johnson, M. A. Pfaller, G. V. Doern
Antimicrobial Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia spp.
Douglas J. Biedenbach, R. N. Jones, S. A. Marshall, D. M. Johnson, M. A. T. Croco
Serum Bactericidal Activity of Moxifloxacin
A. Dalhoff, H. Stass, S. Obertegger
Current Activity of Ciprofloxacin Against Gram-Negative Bacilli in the United States
C. Thornsberry, M. K. Marsilio, M. E. Jones, K. M. Tomfohrde, B. H. Heller, G. Piazza, Daniel F. Sahm
Comparison of In Vitro Activity of Trovafloxacin, Ciprofloxacin and Ceftazidime on Clinical Isolates
Betigül Öngen, Arif Kaygusuz, Lütfiye Öksüz, Kurtulus Töreci
Comparative Activity of 7 Quinolones Against Non-Glucose Fermenting Gram-Negative Bacilli Isolated from Cancer Patients
Maya Balakrishnan, Heidi Mago, Barbara LeBlanc, Kenneth V. I. Rolston
Susceptibility of Anaerobic Gram-Negative Rods to Trovafloxacin
Mirta Litterio, L. Castello, A. Rollet, A. DiMartino, G. Greco, L. Fernández Canigia, M. I. Fernandez, S. Predari, H. Bianchini
Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina
Adriana Sucari, D. Stepanik, J. M. Casellas, G. Tomé, L. Clara, M. Marín, A. Rossi, M. Galas, J. Smayevsky, L. Dufranc, H. Lorenzo, L. de Vedia, H. López
In Vitro Activity of Trovafloxacin, Ciprofloxacin, Azithromycin, Roxithromycin and Clarithromycin Against 355 Clinical Isolates with Different Resistance Patterns
José María Casellas, G. Tomé, M. Gilardoni, G. Pagniez, S. Ivanovic
Trovafloxacin: In Vitro Activity and Comparison with Other Antibacterial Agents
A. Rossi, M. Tokumoto, M. Galas, L. Guelfand, H. Lopardo
Activity of Trovafloxacin Against P. aeruginosa, Methicillin-Resistant S. aureus and Pneumococci
Linda M. Kelly, Michael R. Jacobs, Peter C. Appelbaum
Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
A. Bauernfeind, R. Jungwirth, F. Ratjen
Susceptibility of Pseudomonas aeruginosa to Levofloxacin and Trovafloxacin Based on MICs for Ciprofloxacin and Ofloxacin
Ken B. Waites
Susceptibility of Stenotrophomonas maltophilia to Moxifloxacin, Trovafloxacin, Ofloxacin and Ciprofloxacin
H. Bradford Hawley, Hari M. Polenakovik, John S. Czachor, Susan S. Mueller
Clinafloxacin Antibacterial Activity
Lois M. Ednie, Michael R. Jacobs, Peter C. Appelbaum
Single Dose Pharmacokinetics of the R- and S-Enantiomers of Gatifloxacin in Volunteers
H.-J. Stahlberg, K. Goehler, M. Guillaume, A. Mignot
Advances in Bioanalytical Methodology Used to Characterise Clinical Pharmacokinetics of Moxifloxacin
J.-G. Möller, H. Stass, W. Mück
Impact of Neutropenia on Tissue Penetration of Moxifloxacin and Sparfloxacin in Infected Mice
R. Garraffo, C. Roptin, A. Boudjadja
Effect of Age on Clinafloxacin Pharmacokinetics in Healthy Volunteers
E. J. Randinitis, R. Abel, N. J. Bron, N. J. Hounslow, G. Rausch, A. B. Vassos
Effect of Clinafloxacin on the Pharmacokinetics of Theophylline and Caffeine
E. J. Randinitis, J. R. Koup, G. Rausch, A. B. Vassos
Clinafloxacin Pharmacokinetics in Renal Patients
J. Randinitis, J. R. Koup, G. Rausch, N. J. Bron, N. J. Hounslow, A. B. Vassos, A. J. Sedman
Pharmacokinetics of Oral and Intravenous Clinafloxacin
E. J. Randinitis, J. Brodfuehrer, A. B. Vassos
Drug Interaction Studies with Clinafloxacin and Probenecid, Cimetidine, Phenytoin and Warfarin
E. J. Randinitis, J. R. Koup, N. J. Bron, N. J. Hounslow, G. Rausch, R. Abel, A. B. Vassos, A. J. Sedman
Effects of Food and Antacid on the Pharmacokinetics of Clinafloxacin
C. Alvey, E. J. Randinitis, G. Rausch, A. B. Vassos
In Vitro Pharmacodynamic and Pharmacokinetic Aspects of THP-1 Human Monocyte Uptake, Distribution and Efflux of 14C-Grepafloxacin under Different Conditions
M. A. Dietrich, J. D. Butts, P. Alford, T. J. Ives, I. H. Hall
Clinafloxacin in Serious Infections Caused by Multiply Resistant Pathogens
Kenneth J. Tack, Irene Eiseman, Marcus Zervos
Ciprofloxacin in the Treatment of Nosocomial Meningitis in Neonates and Infants
J. Filka, J. Uher, H. Kurak, T. Šagát, J. Tuharsky, I. Novák, T. Urbanová, K. Kralinsky, S. Dluholucky, T. Krcméryová, V. Krcméry Jr
Bacteraemia and Fungaemia During Ofloxacin Prophylaxis in Cancer Patients
V. Krcméry Jr, J. Trupl, A. Demitrovicova, E. Kukuckova, M. Studena, F. Mateicka
Pharmacodynamics of Trovafloxacin vs Ceftriaxone in Streptococcus pneumoniae
Philip D. Lister, Christine C. Sanders
Use of Intravenous Ciprofloxacin in a Canadian Medical Centre
J. A. Karlowsky, A. S. Gin, R. Cooper, D. J. Hoban, G. G. Zhanel
A Critical Pathway for the Treatment of Community-Acquired Pneumonia
Thomas J. Marrie, Catherine Y. Lau, Susan L. Wheeler, Cindy J. Wong, Margaret K. Vandervoort, Brian G. Feagan
The Microbiological Eradication Rate of First-Line Antibiotic Treatment is a Key Cost Driver in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
L. F. Lacey, T. Volmer, A. M. Harris
The Clinical Failure Rate of First-Line Antibiotic Treatment is the Key Cost Driver in Community-Acquired Lower Respiratory Tract Infections
H. J. J. van Barlingen, T. Volmer, L. F. Lacey
Efficacy of Gatifloxacin in Pneumococcal Respiratory Infection
Rinzo Soejima, Atsushi Saito
Ofloxacin Once Daily Versus Twice Daily in Community-Acquired Pneumonia
V. Kronéry Jr
Oral Trovafloxacin Versus Intravenous Cefoxitin in Elective Hysterectomy
D. R. Luke
Alatrofloxacin Versus Cefotetan in Prophylaxis of Colorectal Surgery
D. R. Luke
Once-Daily Oral Trovafloxacin in the Treatment of Diabetic Foot Infections
R. Daniel
Failure of Alatrofloxacin in Patients with Deep Surgical Infection
V. Gandhi, K. Patel, E. M. Sordillo
Oral Trovafloxacin vs Oral Cefuroxime ± Erythromycin in Community-Acquired Pneumonia
J. Peterson
Trovafloxacin vs High Dose Amoxicillin in the Treatment of Community-Acquired Bacterial Pneumonia
R. Daniel
Trovafloxacin vs Amoxicillin/Clavulanic Acid in the Treatment of Acute Exacerbations of Chronic Obstructive Bronchitis
R. Daniel
IV-to-Oral Switch Therapy with Trovafloxacin Compared with IV Ceftazidime/Oral Ciprofloxacin in the Treatment of Nosocomial Pneumonia
H. P. Bassaris, D. Williams Hopkins, R. Daniel
Trovafloxacin vs Clarithromycin in Patients with Ambulatory Community-Acquired Pneumonia
D. Williams Hopkins
Trovafloxacin vs Amoxicillin in the Oral Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
R. Daniel
Trovafloxacin vs Ceftriaxone/Cefpodoxime ± Erythromycin in Hospitalised Community-Acquired Pneumonia
D. Williams Hopkins, R. Daniel
Trovafloxacin vs Ciprofloxacin ± Clindamycin/Metronidazole in Patients with Nosocomial Pneumonia
D. Williams Hopkins, R. Daniel
Oral Levofloxacin Compared with Clarithromycin in Acute Sinusitis
B. Lasko, C. Y. Lau, R. J. Anstey, C. St-Pierre, A. Y. Martel, F. Diaz-Mitoma
Ciprofloxacin and Cefuroxime Axetil in Acute Community-Acquired Rhinosinusitis
Mark Weis, Kim Hendrick, Kathleen Gravelle, Glenn Tillotson
Are the Fluoroquinolones Comparable in the Treatment of Urinary Tract Infections?
Kurt G. Naber
Effects of Ciprofloxacin in Urinary Tract Infections Using Different Dose Regimens
Kazimierz Janicki
Efficacy and Safety of Ofloxacin in Ureaplasma Infections of the Upper Urinary Tract
Jordan D. Dimitrakov, Dimiter J. Dimitrakov, Georges Rawadi
Ciprofloxacin in the Treatment of Chronic Bacterial Prostatitis
Kurt G. Naber, J. Focht, W. Busch
Activity of Moxifloxacin Against Moraxella catarrhalis and Atypicals
A. Dalhoff
The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Clyde Thornsberry, P. Ogilvie, H. P. Holley, M. L. Hickey, M. E. Jones, I. A. Critchley, D. F. Sahm
Activity of Moxifloxacin Against H. influenzae and H. parainfluenzae
A. Dalhoff
Inhibition of Pneumococcal Topoisomerases by Sitafloxacin
I. Morrissey, J. T. George
Serum Bactericidal Activity of Trovafloxacin Against Drug-Resistant Respiratory Pathogens
Gary E. Stein
Grepafloxacin Activity Against 3000 Canadian Respiratory Tract Pathogens
Daryl J. Hoban, G. G. Zhanel, L. Palatnick, B. Weshnoweski, L. Vercaigne, J. A. Karlowsky
Surveillance of Antimicrobial Resistance among Respiratory Tract Pathogens in the United States, 1997 to 1998
Clyde Thornsberry, Mary L. Hickey, James Kahn, Yolanda Mauriz, Daniel F. Sahm
International Surveillance of Susceptibility to Levofloxacin and Other Agents among Respiratory Pathogens
Clyde Thornsberry, M. L. Hickey, M. E. Jones, I. A. Critchley, G. P. Park, D. F. Sahm
Levofloxacin and Clarithromycin Antipneumococcal Activity
Catherine L. Clark, Michael R. Jacobs, Peter C. Appelbaum
Antipneumococcal Activity of Gatifloxacin by Time-Kill Methodology
Gengrong Lin, Michael R. Jacobs, Peter C. Appelbaum
Antipneumococcal Activity of Gatifloxacin by Agar Dilution MIC
Dianne B. Hoellman, Michael R. Jacobs, Peter C. Appelbaum
Susceptibility of Respiratory Pathogens to Grepafloxacin
R. Cisterna, M. Gobernado, Julio Angel García-Rodríguez
Bactericidal Activity of Grepafloxacin Against Respiratory Pathogens
Franz Daschner, U. Frank, K. Huber
Postantibiotic Effect of Levofloxacin Against Pneumococci
Sheila K. Spangler, Gengrong Lin, Michael R. Jacobs, Peter C. Appelbaum
MICs for Streptococcus pneumoniae with Reduced Penicillin Susceptibility
Vicki A. Luna, Marilyn C. Roberts
Development of High Level Quinolone Resistance in Streptococcus pneumoniae During Sequential Quinolone Therapy
Byungse Suh, Bennett Lorber, Steven Gelone, Allan L. Truant, Thomas D. Gootz
Chondrotoxicity and Target Tissue Kinetics of Ofloxacin in Immature Rats after Multiple Doses
R. Schwabe, Edith Lozo, I. Baumann-Wilschke, Ralf Stahlmann
Chondrotoxicity of Ciprofloxacin in Immature Beagle Dogs
R. Stahlmann, S. Kühner, M. Shakibaei, R. Schwabe, D. van Sickle
Effects of Ofloxacin on the Ultrastructure of Achilles Tendon in Rats
Mehdi Shakibaei, Kerstin Pfister, Rudolf Schwabe, Ralf Stahlmann
Supplementation with Magnesium and Tocopherol Diminishes Quinolone-Induced Chondrotoxicity in Immature Rats
R. Stahlmann, R. Schwabe, K. Pfister, E. Lozo, M. Shakibaei, J. Vormann
Phototoxic Potential of Gatifloxacin, a New Fluoroquinolone Antimicrobial
J. Ferguson, J. McEwen, K. Gohler, A. Mignot, D. Watson
Comparative Antimycobacterial Activity of BAY 12-8039 and Gatifloxacin
Hajime Saito
Fluoroquinolones in the Treatment of Atypical Mycobacterial Infections in AIDS
M. Bassetti, C. Bussolino, M. Cruciani, A. Collidà, V. Del Bono, A. Di Biagio, G. Mazzarello, E. Pontali, E. Mantero, G. Gatti, D. Bassetti
In Vitro Activity of Grepafloxacin Against Chlamydia trachomatis
F. Poutiers, S. Dessus-Babus, F. Leblanc, C. Bébéar, B. de Barbeyrac
Susceptibility of Mycoplasma hominis to Moxifloxacin by E-Test and Agar Dilution
Ken B. Waites, Kay C. Canupp, George E. Kenny
Therapeutic Effects of Sitafloxacin in Rat Uterine Endometritis
Hiroshige Mikamo, Kyoko Kawazoe, Koji Izumi, Teruhiko Tamaya
Pharmacodynamics of Trovafloxacin and Ciprofloxacin Against Ciprofloxacin-Resistant Viridans Streptococci
Philip D. Lister, Christine C. Sanders
Therapeutic Efficacy of Sitafloxacin Against Pseudomonas aeruginosa in a Rat Model of Urinary Tract Infection
Yuichi Kurosaka, Yoshihisa Ishida, Eiko Yamamum, Tsuyoshi Otani, Hiromi Kumon
Pharmacodynamic Activity of Levofloxacin in an In Vitro Model Against Gram-Positive and Gram-Negative Bacteria
B. Wiedemann, E. Pfeil